QSAR models for the prediction of plasma protein binding

BioImpacts

Volumn 3, Issue 1, 2013, Pages 21-27

  Ghafourian, Taravat ^a   Amin, Zeshan ^a  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

ADME; Albumin binding; Distribution; Protein binding; QSAR; Serum proteins

Indexed keywords

ARTICLE; COMPUTER PROGRAM; CORRELATION COEFFICIENT; DATA MINING; EXTERNAL VALIDITY; INTERNAL VALIDITY; NONLINEAR SYSTEM; PHYSICAL CHEMISTRY; PLASMA PROTEIN BINDING; PREDICTIVE VALUE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; STATISTICAL MODEL; VALIDATION PROCESS;

EID: 84879193775     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2013.011     Document Type: Article

References (20)

1. Ction of plasma and tissue protein binding. In: Taylor JB, olmenarejo G. In silico predic Triggle DJ. Comprehensive Medicinal Chemistry II, Vol. 5. Oxford: Elsevier;2007. pp. 847-66.
2. Jambhekar, SS. Physicochemical and biopharmaceutical properties of drug substances and pharmacokinetics. In: Foye WO, Lemke TL, Williams DA, editors. Foye's Principles of Medicinal Chemistry. New York: Lippincott Williams and Wilkins;2008. pp. 247-50.
3. Schmidt S, Gonzalez D, Derendorf H. Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci 2010;99:1107-22.
4. Zsila F, Fitos I, Bencze G, Keri G, Orfi L. Determination of human serum a1 acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors. Curr Med Chem 2009;16:1964-77.
5. Kratochwil N, Huber W, Müller F, Kansy M, Gerber P. Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol 2002;64:1355-74.
6. Urien S, Tillement JP, Barré J. The significance of plasma-protein binding in drug research. In: Testa B, van de Waterbeemd H, Folkers G, Guy R, editors. Pharmacokinetic Optimization in Drug Research. Zürich: Wiley-VCH;2001. pp. 189-97.
7. Bolli A, Marino M, Rimbach G, Fanoli G, Fasano M, Ascenzi P. Flavonoid binding to human serum albumin. Biochem Biophys Res Commun 2010;398:444-9.
8. Zhu L, Yang F, Chen L, Meehan EJ, Huang M. A new drug binding site on human serum albumin and drug-drug interaction studied by X-ray crystallography. J Struct Biol 2008;102:40-9.
9. Barton P, Austin RP, Fessey RE. In Vitro Models for Plasma Binding and Tissue Storage. In: Taylor JB, Triggle DJ. Comprehensive Medicinal Chemistry II, Vol. 5. Oxford: Elsevier;2007. pp. 321-40.
10. Kawai Y, Fujil Y, Akimoto K, Takahashi M. Evaluation of serum protein binding by using in-vitro pharmacological activity for the effective pharmacokinetics profiling in drug discovery. Chem Pharm Bull 2010;58:1051-6.
11. Mayer JM, van de Waterbeemd H. Development of quantitative structure-pharmacokinetic relationships. Environ Health Perspect 1985;61:295-306.
12. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL. Chemoinformatic models to predict binding affinities to human serum albumin. J Med Chem 2001;44:4370-8.
13. Votano RJ, Parham M, Hall LM, Hall HL, Kier BJ, Oloff S, et al. QSAR modelling of human serum protein binding with several modelling techniques utilizing structure-information representation. J Med Chem 2006;49:7169-81.
14. Gleeson MP. Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis. J Med Chem 2007;50:101-12.
15. Lin A. QuaSAR: The MOE System for QSAR. Chemical Computing Group Inc; 2013. Available from: URL: http://www.chemcomp.com/journal/qsar.htm.
16. Dearden JC, Ghafourian T. Hydrogen bonding parameters for QSAR: comparison of indicator variables, hydrogen bond counts, molecular orbital and other parameters. J Chem Inf Comput Sci 1999;39:231-5.
17. Wildman SA, Crippen GM. Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci 1999;39:868-73.
18. Cruciani G, Pastor M, Guba W. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci 2000;11:S29.
19. Ghafourian T, Barzegar-Jalali M, Dastmalchi S, Khavari-Khorasani T, Hakimiha N, Nokhodchi A. QSAR models for the prediction of apparent volume of distribution. Int J Pharm 2006;319:82-97.
20. Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci 2007;26:694-701.